Watertown, MA, United States of America

Maria Beconi

This inventor holds 7 USPTO granted patents and 14 published patent applications and 1 EPO patent. Top assignees: Disc Medicine, Inc., Abbvie Deutschland Gmbh & Co. Kg, Abbvie Deutschland Gmbh and Co Kg. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Beconi. Retrieved from https://idiyas.com/inventor/maria-beconi-yitt2q5e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Maria Beconi: Innovator in Myelofibrosis Treatment

Introduction

Maria Beconi is a notable inventor based in Watertown, MA (US). She has made significant contributions to the field of medical research, particularly in the treatment of myelofibrosis. Her innovative work has led to the development of a unique patent that addresses critical health challenges.

Latest Patents

Maria Beconi holds a patent for "Anti-Hemojuvelin (HJV) Antibodies for Treating Myelofibrosis." This patent represents her commitment to advancing medical science and improving patient outcomes. With 1 patent to her name, she is making strides in the medical community.

Career Highlights

Maria is currently employed at AbbVie Deutschland GmbH & Co. KG, where she continues to push the boundaries of innovation in healthcare. Her work at AbbVie has positioned her as a key player in the development of new therapies for complex diseases.

Collaborations

Throughout her career, Maria has collaborated with esteemed colleagues, including John Quisel and Brian MacDonald. These partnerships have fostered an environment of creativity and innovation, leading to groundbreaking advancements in her field.

Conclusion

Maria Beconi exemplifies the spirit of innovation in the medical field, with her work on myelofibrosis treatment paving the way for future advancements. Her contributions are invaluable, and her dedication to improving healthcare continues to inspire others.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…